INNOVATE

Accredited and funded projects


Between 2005 and 2011, Lyonbiopole accredited 110 R&D collaborative projects representing a total investment of € 537 million for which € 220 million of public aids were obtained from the State (FUI and ANR), Oséo, authorities* and the European Community.
* European Regional Development Fund (EDFR), the Rhone-Alpes Region, Greater Lyon, Grenoble Alpes Métropole, the County Councils of Rhône, Isère and Ain and the Grenoble city.


Funding
Condition

Show Advanced search >> Thematics


Select all - Unselect all

New therapies - Biotherapies
Diagnostic
New technological approaches
Vaccines


Search with...

At least one checked thematic
All thematics that are checked




 FundingProjectState
 
 ANR17MYCLMPACTOngoing
 ANRADDX (PIRIBIO)Ongoing
 ANRADHESIOMAB (EmergenceBIO)Ongoing
 ANRANABIOOngoing
 ANRANRAGEOngoing
 ANRAPTAPROBEOngoing
 ANRAUTOPHAGIEOngoing
 ANRBACTYRKINOngoing
 ANRBIOCAPTOngoing
 ANRCHEMISPIKEOngoing
 ANREBORESISTANCEOngoing
 ANREBV-LYT (MIE)Ongoing
 ANREVODIVOngoing
 ANRFLUDNAGLYCOCHIPSOngoing
 ANRHT-PSAQOngoing
 ANRIGECONTOXOngoing
 ANRNANOPDT (P3N)Ongoing
 ANRNETRISOngoing
 ANRNIVPATH (MIE)Ongoing
 ANRPA-ANTIADH (JCJC)Ongoing
 ANRPNEUMOPGOngoing
 ANRSASTIM (BiotecS)Ongoing
 ANRSMGKINHIBITOngoing
 ANRTREBAROOngoing
 ANRTTMCMVOngoing
 ANRVIRPROBE (PIRIBIO)Ongoing
 ANRACTIVRATFinished
 ANRAPICHROMATINFinished
 ANRBAC-VACFinished
 ANRCAPTCODEFinished
 ANREBIOPROBSFinished
 ANREBVINTERFinished
 ANRFLUINTERPOLFinished
 ANRMETAGENOREGFinished
 ANRNANOGADOFinished
 ANRNEW ANTICANCERDRUGSFinished
 ANRPALUPATCHFinished
 ANRPARASYNVACFinished
 ANRPHOSHO VIRULFinished
 ANRPSEUDOFLUFinished
 ANRYALEFinished

 FUIACILIMAB (AAP12) Ongoing
 FUIALPHAVAC (AAP3)Ongoing
 FUIASPAREC (AAP7)Ongoing
 FUICARBINFEC (AAP3)Ongoing
 FUICOLLECTAIR (AAP4) Ongoing
 FUICOVADIS (AAP9)Ongoing
 FUIDDELPHES (AAP11)Ongoing
 FUIDIVRESCUE (AAP11) Ongoing
 FUIEMERFAB (AAP10)Ongoing
 FUIEXPAND ID (AAP8)Ongoing
 FUIFEMTOKINE (AAP10)Ongoing
 FUIGLIADYS (AAP7)Ongoing
 FUIGR-CAV1 (AAP7)Ongoing
 FUIHYPERBAR (AAP3)Ongoing
 FUIIDITOP (AAP12) Ongoing
 FUIKALLISTE (AAP6)Ongoing
 FUINATHEB (AAP8)Ongoing
 FUIOPTIMABS (AAP10)Ongoing
 FUIPATVAX (AAP8)Ongoing
 FUIPLATINE (AAP5)Ongoing
 FUIPOLYBIO (AAP9)Ongoing
 FUIRHENEPI (AAP9)Ongoing
 FUITBDERMATEST (AAP6)Ongoing
 FUITHERANEAN (AAP7)Ongoing
 FUIBIOTHERAPIC (AAP0)Finished
 FUIDEMINAP (AAP2)Finished
 FUIFIV-VAX (AAP2)Finished
 FUIGAP (AAP0)Finished
 FUIMICRO-VAX (AAP1)Finished
 FUIPRAVIC (AAP0)Finished

 Local authoritiesHU’S-MAPFinished
 Local authoritiesTHYMO 2010Finished

 Oséo ISIADNAOngoing

 PCRDWILDTECH (FP7-KBBE)Ongoing
 PCRDFLUPOL (FP6)Finished
 PCRDNOVADUCK (FP6)Finished

They speak about...


« By helping academic and industrial partners work more closely together, Lyonbiopole is a true catalyst in the emergence and setup of large-scale innovative R&D projects. iDD biotech has two projects accredited by the cluster (PRAVIC & GLIADYS), which are key steps in the development of an SMB. The cluster’s support, through its professionalism and dynamism, enables us to speed up the development of biotech-based candidate medicines, by integrating a number of technological building blocks that rely on local expertise. This is a means to boost players in various sectors – private or public – by pooling everyone’s expertise and know-how, while making the local and national economy more competitive. »


Claudine Vermot-Desroches

iDD-Biotech - Director of R&D

DOCUMENTATION | CONTACT | SEARCH